theory clinical_3_1
imports Main

begin

typedecl entity
typedecl event

consts
  LossOfBRCA2 :: "entity ⇒ bool"
  ChromosomeBreakage :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  InhibitionOfPARP :: "entity ⇒ bool"
  CollapsedReplicationForks :: "entity ⇒ bool"
  DoubleStrandBreaks :: "entity ⇒ bool"
  Result :: "event ⇒ bool"
  PARPInhibitors :: "entity ⇒ bool"
  Directly :: "event ⇒ bool"
  CancerDevelopment :: "entity ⇒ bool"
  Drive :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  GenomicInstability :: "entity"
  TrappingOfPARP1 :: "entity ⇒ bool"
  NonHomologousEndJoining :: "entity ⇒ bool"
  Toxicity :: "entity ⇒ bool"
  Increase :: "event ⇒ bool"
  SingleStrandBreakRepair :: "entity ⇒ bool"
  Prevent :: "event ⇒ bool"
  Lead :: "event ⇒ bool"
  Rely :: "event ⇒ bool"
  On :: "event ⇒ entity ⇒ bool"
  DefectiveHomologousRecombinationRepair :: "entity"
  ErrorProneNonHomologousEndJoining :: "entity"

(* Explanation 1: Loss of BRCA2 causes chromosome breakage *)
axiomatization where
  explanation_1: "∃x y e. LossOfBRCA2 x ∧ ChromosomeBreakage y ∧ Cause e ∧ Agent e x ∧ Patient e y"

(* Explanation 2: Inhibition of PARP results in collapsed replication forks and double strand breaks, and PARP inhibitors directly cause these double strand breaks *)
axiomatization where
  explanation_2: "∃x y z e1 e2. InhibitionOfPARP x ∧ CollapsedReplicationForks y ∧ DoubleStrandBreaks z ∧ Result e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Patient e1 z ∧ PARPInhibitors x ∧ Cause e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Directly e2"

(* Explanation 3: Loss of BRCA2 drives cancer development via genomic instability *)
axiomatization where
  explanation_3: "∃x y e. LossOfBRCA2 x ∧ CancerDevelopment y ∧ Drive e ∧ Agent e x ∧ Patient e y ∧ Via e GenomicInstability"

(* Explanation 4: Trapping of PARP1 at sites of double strand breaks increases non-homologous end joining and increases toxicity *)
axiomatization where
  explanation_4: "∃x y z w e1 e2. TrappingOfPARP1 x ∧ DoubleStrandBreaks y ∧ NonHomologousEndJoining z ∧ Toxicity w ∧ Increase e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Increase e2 ∧ Agent e2 x ∧ Patient e2 w"

(* Explanation 5: PARP inhibitors prevent single strand break repair, leading to replication-associated double strand breaks *)
axiomatization where
  explanation_5: "∃x y z e1 e2. PARPInhibitors x ∧ SingleStrandBreakRepair y ∧ DoubleStrandBreaks z ∧ Prevent e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Lead e2 ∧ Agent e2 x ∧ Patient e2 z"

(* Explanation 6: PARP inhibitors rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA *)
axiomatization where
  explanation_6: "∃x e. PARPInhibitors x ∧ Rely e ∧ Agent e x ∧ On e DefectiveHomologousRecombinationRepair ∧ On e ErrorProneNonHomologousEndJoining"

theorem hypothesis:
  assumes asm: "PARPInhibitors x"
  (* Hypothesis: PARP inhibitors cause replication‐associated double strand breaks by preventing single strand break repair, relying on defective homologous recombination repair and error prone non-homologous end joining to repair DNA *)
  shows "∃x y z e1 e2 e3. PARPInhibitors x ∧ DoubleStrandBreaks y ∧ SingleStrandBreakRepair z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Rely e3 ∧ Agent e3 x ∧ On e3 DefectiveHomologousRecombinationRepair ∧ On e3 ErrorProneNonHomologousEndJoining"
proof -
  (* From the premise, we have the known information about PARP inhibitors. *)
  from asm have "PARPInhibitors x" by simp
  (* There is a logical relation Implies(F, Not(L)), Implies(PARP inhibitors, Not(Single strand break repair)) *)
  (* From this, we can infer that single strand break repair is not possible. *)
  then have "Not(SingleStrandBreakRepair z)" sledgehammer
  (* Using the derived implication Implies(Not(L), M), Implies(Not(Single strand break repair), Replication-associated double strand breaks) *)
  (* We can infer replication-associated double strand breaks. *)
  then have "ReplicationAssociatedDoubleStrandBreaks y" <ATP>
  (* There is a logical relation Implies(F, And(N, J)), Implies(PARP inhibitors, Defective homologous recombination repair & Non-homologous end joining) *)
  (* We can infer both defective homologous recombination repair and non-homologous end joining. *)
  then have "DefectiveHomologousRecombinationRepair ∧ NonHomologousEndJoining" <ATP>
  (* We need to show that PARP inhibitors cause replication-associated double strand breaks by preventing single strand break repair, relying on defective homologous recombination repair and error-prone non-homologous end joining. *)
  then show ?thesis <ATP>
qed

end
